Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of Cisplatin Plus OSI-7904L in Patients With Solid Tumors
This study has been completed.
Study NCT00116896   Information provided by OSI Pharmaceuticals

First Received on June 30, 2005.   Last Updated on January 16, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Advanced Solid Tumors
Additional conditions recognized in this trial
Neoplasms
Interventions listed in this trial
OSI-7904L
Cisplatin
More general drug interventions related to this trial
Antineoplastic Agents
Pharmacologic Actions
Physiological Effects of Drugs
Radiation-Sensitizing Agents
Therapeutic Uses
Sponsors listed in this trial
OSI Pharmaceuticals


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services